DeepMarket Stock Market Blog (Free subscription) | 07/21/2008
Seasonal Patterns found for the following stocks: @Road Inc. (ARDI) over the next 5 trading days. Look at the seasonal patterns for @Road Inc. in context. Adams Respiratory Therapeutics Inc. commom (ARXT) over the next 9 trading days. Look at the seasonal patterns for Adams Respiratory Therapeutics Inc. commom in context. Temecula Valley Bancorp Inc. (TMCV) [...]
News On Women (Free subscription) | 05/28/2008
Schering Plough Corporation (NYSE: SGP) appointed Janet Barth Vice President, Investor Relations. Janet had been Senior Vice President, Investor Relations at Adams Respiratory Therapeutics. Read more about it in the prnewswire press release.
PR News Wire (Free subscription) | 01/24/2008
CHESTER, N.J. and SLOUGH, England, Jan. 24 /PRNewswire-FirstCall/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") announced today that it has completed its previously announced cash tender offer (the "Offer") for all outstanding shares of common stock (the "Shares") of Adams Respiratory Therapeutics, Inc. (Nasdaq: ) ("Adams"). The Offer expired, as scheduled, at midnight, New York City...
Reuters UK (Free subscription) | 01/08/2008
(Reuters) - Adams Respiratory Therapeutics and Britain's Reckitt Benckiser Group said they received antitrust approval from U.S. regulators for the acquisition of the U.S.-based drugmaker by the British company.
PR News Wire (Free subscription) | 01/08/2008
SLOUGH, U.K. and CHESTER, N.J., Jan. 8 /PRNewswire-FirstCall/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams Respiratory Therapeutics, Inc. (Nasdaq: ) ("Adams") announced today that they have received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) relating to the previously announced tender offer to purchase all of...
Red Orbit (Free subscription) | 12/21/2007
CHESTER, N.J. and SLOUGH, England, Dec. 21 /PRNewswire-FirstCall/ -- Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser"), today commenced its previously announced cash tender offer (the "Offer") for all of the outstanding shares of Adams Respiratory Therapeutics, Inc. ("Adams").
Scotsman.com (Free subscription) | 12/12/2007
JP MORGAN yesterday raised its price target on Reckitt Benckiser to £31.50 from £30, saying the group's acquisition of US drugs group Adams Respiratory Therapeutics would help it reach its goal of doubling sales by 2012.
Fool.com (Free subscription) | 12/11/2007
Reckitt Benckiser purchases Adams Respiratory Therapeutics for $2.3 billion.
Market Wire - Investment Opinion (Free subscription) | 12/11/2007
WESTON, FL (MARKET WIRE) Wall Street News Alert's "stocks to watch" this morning are: ER Urgent Care Centers (PINKSHEETS: ERUC), THQ Inc. (NASDAQ: THQI), Claymont Steel Holdings, Inc. (NASDAQ: PLTE) and Adams Respiratory Therapeutics (NASDAQ: ARXT).
DealBook (Free subscription) | 12/11/2007
Britain's Reckitt Benckiser, the world's largest household products manufacturer, agreed Monday to buy U.S. cough and congestion medicine group Adams Respiratory Therapeutics for $60 a share in cash, or $2.3 billion, The move, which marks Reckitt's entry into the U.S. healthcare market, comes as the maker of Lysol disinfectant is expanding into healthcare. The takeover follows [...]
Financial Time (Free subscription) | 12/11/2007
Reckitt Benckiser, the UK household goods maker, yesterday agreed to buy Adams Respiratory Therapeutics, a small US pharmaceutical group, for $2.3bn as it outlined...
Financial Time (Free subscription) | 12/11/2007
Reckitt Benckiser, the UK household goods maker, yesterday agreed to buy Adams Respiratory Therapeutics, a small US pharmaceutical group, for $2.3bn as it outlined...
The Independent (Free subscription) | 12/11/2007
Reckitt Benckiser, the owner of brands such as Lemsip and Dettol, took its first steps into the US healthcare market yesterday, unveiling a £1.1bn all-cash deal to buy Adams Respiratory Therapeutics.
Times Online (Free subscription) | 12/11/2007
Reckitt Benckiser, the Anglo-Dutch household products giant, is to enter the over-the-counter medicines market in the United States after agreeing to buy Adams Respiratory Therapeutics for $2.3 billion ($£1.1 billion) in cash.
Sound Money Tips (Free subscription) | 12/10/2007
Reckitt Benckiser plc said Monday it will purchase Adams Respiratory Therapeutics (ARXT) for $2.3 billion in cash. Complete Story »
